Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Subscribe
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
dexamethasone
Pharma
Optifye and DelSiTech partner on controlled-release eye drops
The exclusive license agreement covers a candidate that uses DelSiTech technology to cut the number of times a day patients need to use drops.
Nick Paul Taylor
Mar 29, 2022 7:50am
J&J touts Darzalex survival win as Sanofi's Sarclisa draws near
Jun 12, 2021 3:00am
Sanofi's Sarclisa keeps pressure on J&J's Darzalex with new nod
Apr 2, 2021 10:53am
Regeneron, Gilead meds star in Trump's COVID treatment plan
Oct 2, 2020 4:55pm
Steroids save lives of very ill COVID-19 patients: studies
Sep 3, 2020 11:15am
Novartis promises zero profit for 15 COVID-19 drugs
Jul 16, 2020 11:37am
